Skip to main content
Clinical Trials/DRKS00004372
DRKS00004372
Recruiting
Not Applicable

Molecular genetic analysis of patients with Bernard Soulier syndrome - BSS

ZLB Behring GmbH0 sites20 target enrollmentSeptember 11, 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
D69.1
Sponsor
ZLB Behring GmbH
Enrollment
20
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 11, 2012
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
ZLB Behring GmbH

Eligibility Criteria

Inclusion Criteria

  • bleeding symptoms, thrombocytopathy, giant platelets, thrombocytopenia, impaired platelet agglutination after stimulation with Ristocetin.

Exclusion Criteria

  • lack of patient's or parents' consent to perform molecular genetic analysis.

Outcomes

Primary Outcomes

Not specified

Similar Trials